WW International, Inc. 正在扩展其集成GLP-1平台,通过纳入Wegovy®片剂的使用权,此举旨在为长期体重健康设定一个新的行业标准。这一战略举措将增强公司为会员提供的体重管理解决方案组合,结合了行为改变支持与先进的药物治疗方案,以应对复杂的体重管理挑战。
WW International, Inc. 正在扩展其集成GLP-1平台,通过纳入Wegovy®片剂的使用权,此举旨在为长期体重健康设定一个新的行业标准。这一战略举措将增强公司为会员提供的体重管理解决方案组合,结合了行为改变支持与先进的药物治疗方案,以应对复杂的体重管理挑战。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.